Salbutamol: A Drug Study On

Download as docx, pdf, or txt
Download as docx, pdf, or txt
You are on page 1of 9

A Drug Study on

SALBUTAMOL

In partial fulfillment of the


Requirements in NCM 209- RLE
PEDIATRIC ROOM NURSING ROTATION

Submitted to:

Ma’am Weniegin Ruth Dullin, RN, MN

Submitted by:

Aliana Nicole B. Emuy, St. N.


SUBGROUP 4 - BSN 2J

January 25, 2021


GENERIC NAME:
Salbutamol

BRAND NAME:
Proventil, Vospira ER, Accuneb, Ventodisk, Ventolin

PREGNANCY CATERGORY: C

USES: Treatment or prevention of bronchospasm due to reversible obstructive airway disease, prevention of exercise-
induced bronchospasm.

INDICATION
To prevent exercise-induced bronchospasm and to treat or prevent bronchospasms in patient with reversible
obstructive airway disease or acute bronchospatic attack.

CONTRAINDICATIONS

Hypersensitivity to albuterol. Severe hypersensitivity to milk protein (powder for inhalation).

Cautions: Hypertension, cardiovascular disease, hyperthyroidism, diabetes, HF, convulsive disorders, glaucoma,
hypokalemia, arrhythmias.
CLASSIFICATION

PHARMACOTHERAPEUTIC: Sympathomimetic (adrenergic anogist).

CLINICAL: Bronchodilator.

ORDERED DOSE AND FREQUENCY

Acute Bronchospasm, Exacerbation of Asthma

ROUTE OF ADMINISTRATION DOSE FREQUENCY

INHALATION ADULTS, ELDERLY, CHILDREN q20min up to 4 hrs, then q1–4h as


OLDER THAN12 YRS: needed.
(ACUTE,SEVERE): 4 – 8 puffs

CHILDREN 12 YRS AND YOUNGER: q20min


(Acute, Severe): 4 – 8 puffs for 3 doses, then q1–4h as needed.

NEBULIZATION ADULTS, ELDERLY, CHILDREN


OLDER THAN12 YRS:
(ACUTE,SEVERE):
q20min for 3 doses
2.5 – 5 mg
q1–4h
2.5 – 10 mg continuously
10 – 15 mg/hr
Chronic Bronchospasm

ROUTE OF ADMINISTRATION DOSE FREQUENCY

PO ADULTS, CHILDREN OLDER THAN 3 – 4 times/day


12 YRS: 2–4 mg
Maximum: 8 mg 4 times/day

3 – 4 times/day
ELDERLY: 2 mg
4 times/day
Maximum: 8 mg
3 – 4 times/day
CHILDREN 6–12 YRS: 2 mg Per day
Maximum: 24 mg

CHILDREN 2–5 YRS: 0.1–0.2 3 times/day


mg/kg/dose
Maximum: 24 mg 3 times/day

PO: (EXTENDED RELEASE) ADULTS, CHILDREN OLDER THAN q12h


12 YRS: 4– 8 mg
Maximum: 32 mg/day

CHILDREN 6–12 YRS: 4 mg q12h.


Maximum: 24 mg/day.

NEBULIZATION ADULTS, ELDERLY, CHILDREN 12 3–4 times/day as needed.


YRS AND OLDER: 2.5 mg

CHILDREN 2–11 YRS: 0.63–1.25 mg 3–4 times/day as needed.


INHALATION ADULTS, ELDERLY, CHILDREN: 2 q4–6h as needed.
puffs

Exercise-Induced Bronchospasm

ROUTE OF ADMINISTRATION DOSE FREQUENCY

INHALATION ADULTS, ELDERLY, CHILDREN 5 5 minutes before exercise


YRS AND OLDER: 2 puffs

5 minutes before exercise


CHILDREN 4 YRS AND YOUNGER:
1–2 puffs

Dosage in Renal/Hepatic Impairment

No Dose Adjustment

MODE OF ACTION

Stimulates beta2 -adrenergic receptors in lungs, resulting in relaxation of bronchial smooth muscle. Therapeutic Effect:
Relieves bronchospasm and reduces airway resistance.
SIDE EFFECTS

Frequent 27% - 4% : Occasional 3% - 2%: Rare:

Headache, restlessness, Insomnia, asthenia, altered taste. Drowsiness, diarrhea, dry mouth,
nervousness, tremors, nausea, flushing, diaphoresis, anorexia.
dizziness, throat dryness and irritation, Inhalation: Dry, irritated mouth or
pharyngitis, B/P changes including throat; cough, bronchial irritation.
hypertension, heartburn, transient
wheezing.

ADVERSE EFFECTS/ TOXIC REACTIONS

Excessive sympathomimetic stimulation may produce palpitations, ectopy, tachycardia, chest pain, slight increase in
B/P followed by substantial decrease, chills, diaphoresis, blanching of skin.

Too-frequent or excessive use may lead to decreased bronchodilating effectiveness and severe, paradoxical
bronchoconstriction.

DRUG INTERACTION

DRUG - Beta-blockers (e.g., carvedilol, labetalol, metoprolol)


antagonize effects. May produce bronchospasm.
Atomoxetine, MAIOs, tricyclic antidepressants (e.g.,
amitriptyline, doxepin) may potentiate cardiovascular
effects. May increase effects of loop diuretics (e.g.,
furosemide) (produce hypokalemia),
sympathomimetics (increase CNS stimulation).

HERBAL - St. John’s wort may decrease level/effects. Ephedra,


yohimbe may cause CNS stimulation.

FOOD - None Known.

LAB VALUES - May increase blood glucose level. May decrease serum
potassium level.

NURSING RESPONSIBILITIES

BASELINE ASSESSMENT

1. Assess lung sounds, pulse, B/P, color, characteristics of sputum noted.


2. Offer emotional support (high incidence of anxiety due to difficulty in breathing and
sympathomimetic response to drug).

INTERVENTION/EVALUATION

1. Check and verify with doctor’s order and Kardex.


2. Observe rights in medication administration such as giving the right drug to the right patient using the right route
and at the right time.
3. Monitor rate, depth, rhythm, type of respiration; quality and rate of pulse; EKG;
serum potassium, glucose; ABG determinations.
4. Assess lung sounds for wheezing (bronchoconstriction), rales.
5. Administer accurately because adverse reactions and tolerance might occur.
6. Auscultate lungs for presence of adventitious breath sounds that may signal pulmonary edema, airway resistance
or bronchospasm.
7. Inspect client’s nail bed and oral mucosa for pallor.

PATIENT/FAMILY TEACHING

1. Follow guidelines for proper use of inhaler.


2. A health care provider will show you know to properly prepare and use your
medication. You must demonstrate correct preparation and injection techniques before using medication.
3. Increase fluid intake (decreases lung secretion viscosity)..
4. Do not take more than 2 inhalations at any one time (excessive use may produce paradoxical bronchoconstriction
or decreased bronchodilating effect).
5. Rinsing mouth with water immediately after inhalation may prevent mouth/throat dryness.
6. Avoid excessive use of caffeine derivatives (chocolate, coffee, tea, cola, cocoa).
BIBLIOGRAPHY

Kizior, R. J. (2019). Saunders Nursing Drug Handbook 2019. St. Louis: Elsevier. 233-237.

Nurse’s Drug Handbook. (2018). 17th edn. USA: Jones & Bartlett Learning.

Salbutamol Drug Study. (2018, May 24.) Retrieved from https://rnspeak.com/salbutamol-drug-study/

You might also like